Harry Gillis
Stock Analyst at Berenberg Bank
(4.20)
# 1,466
Out of 4,476 analysts
70
Total ratings
69.6%
Success rate
17.7%
Average return
Main Sectors:
Stocks Rated by Harry Gillis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | kr 525.00 → kr 550.00 | $479.00 | +14.82% | 19 | Jun 23, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $155 → $140 | $97.55 | +43.52% | 12 | May 11, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Upgraded: Buy | €215.00 → €250.00 | $226.60 | +10.33% | 3 | Apr 24, 2026 | |
| SWX: TECN Tecan Group AG | Maintained: Buy | CHF 205.00 | $176.90 | +15.88% | 9 | Apr 21, 2026 | |
| ATAI AtaiBeckley | Maintained: Buy | $13 → $14 | $5.19 | +169.75% | 10 | Apr 20, 2026 | |
| QGEN Qiagen | Maintained: Buy | $53 → $57 | $40.10 | +42.68% | 7 | Feb 12, 2026 | |
| MRNA Moderna | Maintained: Hold | $26 → $32 | $79.76 | -59.88% | 10 | Jan 22, 2026 |
Swedish Orphan Biovitrum AB (publ)
Jun 23, 2026
Maintained: Buy
Price Target: kr 525.00 → kr 550.00
Current: $479.00
Upside: +14.82%
BioNTech SE
May 11, 2026
Maintained: Buy
Price Target: $155 → $140
Current: $97.55
Upside: +43.52%
Sartorius Aktiengesellschaft
Apr 24, 2026
Upgraded: Buy
Price Target: €215.00 → €250.00
Current: $226.60
Upside: +10.33%
Tecan Group AG
Apr 21, 2026
Maintained: Buy
Price Target: CHF 205.00
Current: $176.90
Upside: +15.88%
AtaiBeckley
Apr 20, 2026
Maintained: Buy
Price Target: $13 → $14
Current: $5.19
Upside: +169.75%
Qiagen
Feb 12, 2026
Maintained: Buy
Price Target: $53 → $57
Current: $40.10
Upside: +42.68%
Moderna
Jan 22, 2026
Maintained: Hold
Price Target: $26 → $32
Current: $79.76
Upside: -59.88%